Background: As women receiving hemodialysis are evaluated frequently by the
nephrologist, we hypothesized that women's health issues are better addres
sed in the dialysis patient than in the general population. Patients and me
thods: We surveyed the female patients in our dialysis population. 97% of t
he women approached agreed to participate. We found that 55.4% of our cohor
t had received routine gynecologic care. 50% of the women had undergone a P
apanicolaou (Pap) smear in the last year. Of the women aged 40 - 50, 55% ha
d undergone a mammogram in the last 2 years. In women over age 50, 71% rece
ived an annual mammogram. Results: We found that 57% of the women were amen
orrheic before starting renal replacement therapy while 16% had become amen
orrheic after dialysis was started. 27% were still menstruating at the time
of the survey. Only 4% of the amenorrheic women interviewed were currently
on hormone replacement therapy (HRT) as compared with 20% of women in our
general medical clinics. While 67% stated that they would take hormone repl
acement if offered, 89% had never been offered HRT. Variables that positive
ly correlated with willingness to take HRT were a history of a hysterectomy
and more skilled work history. Although nephrologists surveyed at our acad
emic facility agreed that amenorrheic women with renal disease benefited fr
om HRT, many believed that it is not the role of the nephrologist to prescr
ibe it. Conclusion: Despite frequent contacts with medical providers, women
's health issues for patients on dialysis may not receive the same attentio
n as women in the general population.